After a tweet from a fake corporate account last week claimed Eli Lilly would give insulin away for free, the drugmaker’s chief executive officer acknowledged the need to do a better job of widening access to the life-saving diabetes treatment and change perceptions of its existing efforts to do so.
“It probably highlights that we have more work to do to bring down the cost of insulin for more people,” David Ricks said at the STAT Summit, where he made his first public remarks since the episode erupted. He added Lilly attempted to get the tweet taken down quickly, but the company found it difficult to secure cooperation from Twitter, which is in turmoil after Elon Musk purchased the company and cut staff.
Create a display name to comment
This name will appear with your comment